Toshifumi Sugitani

Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan

Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama et al. · Annals of the Rheumatic Diseases · 2016 · 93 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Comparison of 5-Year Survival After Acute Myocardial Infarction Using Angiotensin-Converting Enzyme Inhibitor Versus Angiotensin II Receptor Blocker

Masahiko Hara, Yasuhiko Sakata, Daisaku Nakatani et al. · The American Journal of Cardiology · 2014 · 37 citations

Medicine, Cardiology, Pharmacology +12

A simple and flexible graphical approach for adaptive group-sequential clinical trials

Toshifumi Sugitani, Frank Bretz, Willi Maurer · Journal of Biopharmaceutical Statistics · 2014 · 27 citations · Full text

Public Health, Biostatistics, Pharmacology +17

Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset

Tomomi Kimura, Robert Snijder, Toshifumi Sugitani · Journal of Infection and Chemotherapy · 2019 · 21 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +13

Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital

Wataru Fukuda, Tadamasa Hanyu, Masaki Katayama et al. · Arthritis Research & Therapy · 2019 · 21 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17